Moderna is developing an mRNA Ebola vaccine as a deadly outbreak spreads through Congo

CEPI is committing up to $50 million to support Moderna's vaccine candidate for the strain with no approved shot

NurPhoto / Getty Images

Moderna $MRNA is partnering with the Coalition for Epidemic Preparedness Innovations to develop a vaccine against Bundibugyo ebolavirus, the strain driving an ongoing outbreak in the Democratic Republic of Congo and neighboring Uganda for which no licensed vaccine exists.

CEPI has committed up to $50 million to support preclinical testing and Phase 1 clinical trials of Moderna's messenger RNA vaccine candidate. CEPI said it will also fund simultaneous manufacturing of doses so that large-scale Phase 2 and Phase 3 trials can begin immediately if Phase 1 data supports........

© Quartz